risedronic acid has been researched along with Metaplasia in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Metaplasia: A condition in which there is a change of one adult cell type to another similar adult cell type.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geneva, II | 1 |
| Eagle, RC | 1 |
| Barker-Griffith, A | 1 |
| Stefanyszyn, M | 1 |
| Weisenthal, R | 1 |
1 other study available for risedronic acid and Metaplasia
| Article | Year |
|---|---|
Squamous metaplasia of the conjunctiva: a previously unrecognized adverse effect of risedronate sodium.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Conjunctiva; Conjunctival Diseases; Epithelial | 2013 |